Tulane University Researchers Develop Synthetic Antibody Against COVID-19
June 23, 2020
June 23, 2020
NEW ORLEANS, Louisiana, June 23 -- Tulane University issued the following news release:
Scientists working to develop drugs against COVID-19 are focused on interrupting its interaction with ACE2, an enzyme the spike protein on the surface of the coronavirus latches onto, like a key, to enter and infect healthy cells.
Researchers at Tulane University School of Medicine have designed a synthetic protein that acts as a decoy to intercept and neutralize the virus before it . . .
Scientists working to develop drugs against COVID-19 are focused on interrupting its interaction with ACE2, an enzyme the spike protein on the surface of the coronavirus latches onto, like a key, to enter and infect healthy cells.
Researchers at Tulane University School of Medicine have designed a synthetic protein that acts as a decoy to intercept and neutralize the virus before it . . .